Knowledge Hub

Your Gateway to Expert Insights, Research, and Tools

Filter by

Advenion Nutrition Announces New Scientific Publication on Safforce+® in Nutrients (peer-reviewed journal)

Published in Nutrients, this study shows that a safranal-standardized saffron extract improves anxiety, memory, and metabolic regulation in aging through neuropeptide and neuroinflammatory pathway modulation.

Safforce+® – A Safranal-Standardized Saffron Extract Improves Mood, Cognition, and Metabolic Resilience in Aging published in Nutrients (peer-reviewed journal)

Published in Nutrients, this study shows that Safforce+®, a safranal-standardized saffron extract, improves anxiety, memory, and metabolic regulation in aging through neuropeptide and neuroinflammatory pathway modulation.

Endocrine and Metabolic Impact of Innosweet®: A Functional Sweetener Approach Published in Pharmaceutics ( peer-reviewed journal)

Published in Pharmaceutics, this study shows that Innosweet® acts as a functional sweetener, reducing insulin demand and supporting metabolic and liver health while preserving natural sweetness.

Pharmacokinetics and Endocrine Effects of D-Pinitol Delivered Through Innosweet® in Healthy Humans Published in Nutrients (peer-reviewed journal)

Published in Nutrients, this clinical study shows that Innosweet® delivers bioavailable D-Pinitol while supporting insulin-sparing endocrine responses and metabolic balance without affecting blood glucose.

Gyneos® Improves Oocyte Quality, Embryo Development and Implantation in PCOS and Aging Models Published in International Journal of Molecular Sciences (peer-reviewed journal)

Published in the International Journal of Molecular Sciences, this study shows that Gyneos® improves oocyte quality, embryo development, and implantation in PCOS and aging models by restoring metabolic and hormonal balance.

Early D-Chiro-Inositol Intervention Restores Brain Insulin and Synaptic Signaling in Alzheimer’s Disease Published in Nutrients (MDPI, peer-reviewed journal, 2025)

Published in Nutrients (2025), this study shows that early D-chiro-inositol intervention restores brain insulin signaling and synaptic balance in a humanized Alzheimer’s model, with enhanced benefits in females.

Gyneos® Improves Brain Insulin Signaling and Cognitive Function in Female Alzheimer’s Models

Published in Nutrients, this study shows that Gyneos® restores brain insulin signaling and improves cognition in female Alzheimer’s models, reinforcing its role in women-specific cognitive aging strategies.

Gyneos® as a Metabolic and Hormonal Modulator in Women’s Health and Aging Published in Biomedicines (peer-reviewed journal)

Published in Biomedicines, this review positions Gyneos® as a key metabolic and hormonal regulator linking fertility, PCOS, and age-related metabolic and cognitive changes in women.

Pharmacokinetics and Endocrine Effects of Agelity® in Healthy Human Volunteers Published in Nutrients (MDPI, peer-reviewed journal, Human Study)

Published in Nutrients, this human clinical trial confirms that Agelity® reduces insulin demand while maintaining normal glycemia, supporting its role as a safe, insulin-sparing nutraceutical for metabolic health and healthy aging.

Agelity® as an Insulin-Sparing Metabolic Regulator with Pancreatic Protective Effects Published in Nutrients (MDPI, peer-reviewed journal, 2020) Copiar

Published in Nutrients, this study shows that Agelity® reduces insulin secretion while maintaining normal glycemia, supporting its role as an insulin-sparing nutraceutical with pancreatic protective potential.

Agelity® as an Insulin-Sparing Metabolic Regulator with Pancreatic Protective Effects Published in Nutrients (MDPI, peer-reviewed journal, 2020)

Published in Nutrients, this study shows thatAgelity® reduces insulin secretion while maintaining normal glycemia, supporting its role as an insulin-sparing nutraceutical with pancreatic protective potential.

Agelity® as a Multi-Faceted Disease Modifier in Alzheimer’s Disease Published in Nutrients (MDPI, peer-reviewed journal, 2024)

Published in Nutrients (2024), this study shows that D-Pinitol acts as a multi-faceted disease modifier in Alzheimer’s disease, improving cognition, reducing amyloid and tau pathology, and restoring metabolic and gut–brain axis balance.

Agelity® Brain Insulin Resistance and Tau Pathology: New Insights for Neurodegenerative Disorders Published in Neural Regeneration Research (peer-reviewed journal, 2024)

Published in Neural Regeneration Research, this review links Agelity® to key mechanisms connecting brain insulin resistance and tau pathology, reinforcing its potential role in cognitive aging and neurodegenerative health strategies.

Agelity® Reduces Tau Hyperphosphorylation via CDK5 Regulation Published in British Journal of Pharmacology (Wiley, high-impact peer-reviewed journal)

Published in the British Journal of Pharmacology, this study reveals that Agelity® reduces tau hyperphosphorylation by regulating CDK5 activity, supporting its role as a science-driven nutraceutical approach for tau-related neurodegeneration and cognitive aging.

Agelity® D-Pinitol Activates Brain Insulin Signaling via PI3K/Akt Pathway Published in Nutrients (MDPI, peer-reviewed journal)

Published in Nutrients, this study shows that Agelity® activates brain insulin signaling via the PI3K/Akt pathway, supporting its role as an insulin-sparing metabolic modulator with relevance in cognitive aging and metabolic health.

Agelity® as a as a Metabolic Modulator in Aging and Neurodegenerative Disorders Published in Biomedicines (MDPI, peer-reviewed journal)

Published in the peer-reviewed journal Biomedicines, this study positions D-Pinitol as a key metabolic regulator connecting insulin signaling, aging, and neurodegeneration, supporting its role in metabolic and cognitive longevity strategies.